ALKEM LABORATORIES LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.
Alkem Laboratories Limited engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India.
alkem laboratories limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Generic. alkem laboratories limited is SEBI Listed Company (India) and having:-
ISIN (An International Securities Identification Number): INE540L01014
Equity Stock (National Stock Exchange) Symbol: ALKEM
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=ALKEM
BSE Link IS: https://www.bseindia.com/stock-share-price/alkem-laboratories-ltd/ALKEM/539523/
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did!
Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries
32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged.
We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA – UK, SAHPRA-South Africa, TGA – Australia, ANVISA – Brazil, WHO – Geneva, TPD – Health Canada, PPB – Kenya, NDA – Uganda, MOH – Sudan, INVIMA – Colombia, TFDA – Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries.
Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it’s Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.
Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.
Alkem Laboratories Ltd. stand with []
Company Website: http://www.alkemlabs.com/
Company Website2: http://www.alkemlabs.com/
LinkedIn page URL: https://in.linkedin.com/company/alkem-laboratories-ltd
Wiki Profile URL: https://en.wikipedia.org/wiki/Alkem_Laboratories
Popular Search Keywords: alkem laboratories limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Generic industry
#alkem #laboratories #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #generic #industry
